title: HPV-related (pre)malignancies of the female anogenital tract in renal transplant recipients.
abstract: Renal transplantations (RTs) are performed routinely in many countries. After RT, the administration of lifelong immunosuppressive therapy is required. As a consequence, renal transplant recipients (RTRs) have a high risk to develop virus-associated (pre)malignancies, such as Human papillomavirus (HPV) related anogenital (pre)malignancies. It is known that the majority of the RTRs are infected with HPV and that these women have a 14-fold increased risk of cervical cancer, up to 50-fold of vulvar cancer and up to 100-fold of anal cancer. Often, treatment of these lesions requires concessions and may be suboptimal as radiation therapy and extensive surgery may damage the renal transplant. Therefore, prognosis may be compromised due to inadequately treated malignancies. Especially for these immunocompromised patients prevention is of utmost importance. Yearly cervical cancer screening for RTRs is advised, but appears to be executed poorly. For the future, optimizing screening and prevention of anogenital (pre)malignancies is an important issue for women after RT. This review gives a broad overview of all aspects regarding HPV-related (pre)malignancies of the female anogenital tract in RTRs.
authors.affiliation: Department of Obstetrics & Gynaecology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
authors.forename: F
authors.initials: F
authors.lastname: Hinten
authors.forename: K A P
authors.initials: KA
authors.lastname: Meeuwis
authors.forename: M M
authors.initials: MM
authors.lastname: van Rossum
authors.forename: J A
authors.initials: JA
authors.lastname: de Hullu
mesh_terms: D000328:Adult; D001005:Anus Neoplasms / Q000209:etiology* / Q000473:pathology* / Q000517:prevention & control; D005260:Female; D005833:Genital Neoplasms, Female / Q000209:etiology* / Q000473:pathology* / Q000517:prevention & control; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000150:complications*; D011230:Precancerous Conditions